The Emerging Role of Mitochondrial Targeting in Kidney Disease
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Renal disease affects millions of people worldwide, imposing an enormous financial burden for health-care systems. Recent evidence suggests that mitochondria play an important role in the pathogenesis of different forms of renal disease, including genetic defects, acute kidney injury, chronic kidney disease, aging, renal tumors, and transplant nephropathy. Renal mitochondrial abnormalities and dysfunction affect several cellular pathways, leading to increased oxidative stress, apoptosis, microvascular loss, and fibrosis, all of which compromise renal function. Over recent years, compounds that specifically target mitochondria have emerged as promising therapeutic options for patients with renal disease. Although the most compelling evidence is based on preclinical studies, several compounds are currently being tested in clinical trials. This chapter provides an overview of the involvement of mitochondrial dysfunction in renal disease and summarizes the current knowledge on mitochondria-targeted strategies to attenuate renal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Cassidy-Stone, A., Chipuk, J. E., Ingerman, E., Song, C., Yoo, C., Kuwana, T., Kurth, M. J., Shaw, J. T., Hinshaw, J. E., Green, D. R., et al. (2008) · Developmental Cell · doi:10.1016/j.devcel.2007.11.019 · Cited by 1,200
Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury
Ong, S.-B., Subrayan, S., Lim, S. Y., Yellon, D. M., Davidson, S. M., & Hausenloy, D. J. (2010) · Circulation · doi:10.1161/circulationaha.109.906610 · Cited by 986 · cited 1×
“…and fibroblast cells with mdivi-1 reduces mitochondrial membrane potential and blastocyst cell number, increasing ROS and apoptosis (Yeon et al. 2015), its delivery in vivo inhibits mPTP opening and protects cardiomyocytes exposed to renal (Sumida et al. 2015) and cardiac (Ong et al. 2010) IRI.”
BackgroundThe Interplay Between Mitochondrial Dynamics and Mitophagy
Twig, G., & Shirihai, O. S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3779 · Cited by 778 · cited 1×
“Furthermore, activation of DRP-1 triggers mitochondrial depolarization and subsequent mitophagy (Twig and Shirihai 2011).”
BackgroundRegulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models
Brooks, C., Wei, Q., Cho, S.-G., & Dong, Z. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37829 · Cited by 735 · cited 1×
“In rodent models of cisplatin-induced nephrotoxicity, mitochondrial outer membrane permeabilization triggers mitochondrial fragmentation, cytochrome-c release, and apoptosis (Brooks et al. 2009).”
BackgroundCyclosporine before PCI in Patients with Acute Myocardial Infarction
Cung, T.-T., Morel, O., Cayla, G., Rioufol, G., Garcia-Dorado, D., Angoulvant, D., Bonnefoy-Cudraz, E., Guérin, P., Elbaz, M., Delarche, N., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505489 · Cited by 713
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease
Sharma, K., Karl, B., Mathew, A. V., Gangoiti, J. A., Wassel, C. L., Saito, R., Pu, M., Sharma, S., You, Y.-H., Wang, L., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020126 · Cited by 571 · cited 2×
“suggesting suppression of mitochondrial activity in diabetic kidney disease (Sharma et al. 2013).”
BackgroundPrevention of diabetic nephropathy in Ins2+/−AkitaJ mice by the mitochondria-targeted therapy MitoQ
Chacko, B. K., Reily, C., Srivastava, A., Johnson, M. S., Ye, Y., Ulasova, E., Agarwal, A., Zinn, K. R., Murphy, M. P., Kalyanaraman, B., et al. (2010) · Biochemical Journal · doi:10.1042/bj20100308 · Cited by 204
Dare, A. J., Bolton, E. A., Pettigrew, G. J., Bradley, J. A., Saeb-Parsy, K., & Murphy, M. P. (2015) · Redox Biology · doi:10.1016/j.redox.2015.04.008 · Cited by 202 · cited 1×
“For example, administration of MitoQ prior to bilateral renal ischemia in mice decreases mitochondrial oxidative damage and renal dysfunction (Dare et al. 2015).”
BackgroundDeficient Autophagy Results in Mitochondrial Dysfunction and FSGS
Kawakami, T., Gomez, I. G., Ren, S., Hudkins, K., Roach, A., Alpers, C. E., Shankland, S. J., D’Agati, V. D., & Duffield, J. S. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111202 · Cited by 176 · cited 5×
“Taken together, these studies implicate mitochondrial structural and functional alterations in the pathogenesis of ischemic CKD. Glomerulonephritis Chronic glomerulonephritis accounts for approximately 10% of all causes of CKD. Accumulation of abnormal-shaped mitochondria are commonly found in podocytes, distal tubule…”
BackgroundInfluential
Cited by
Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease
Podkowińska, A., & Formanowicz, D. (2020) · Antioxidants · doi:10.3390/antiox9080752 · Cited by 356
Miguel, V., Tituaña, J., Herrero, J. I., Herrero, L., Serra, D., Cuevas, P., Barbas, C., Puyol, D. R., Márquez-Expósito, L., Ruiz-Ortega, M., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140695 · Cited by 344
Gyurászová, M., Gurecká, R., Bábíčková, J., & Tóthová, Ľ. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5478708 · Cited by 322
Mitochondria Damage and Kidney Disease
Duann, P., & Lin, P.-H. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-55330-6_27 · Cited by 258
Melatonin ameliorates the drug induced nephrotoxicity: Molecular insights
Raza, Z., & Naureen, Z. (2020) · Nefrología · doi:10.1016/j.nefro.2019.06.009 · Cited by 43
Metadata
- Authors
- Eirin, A., Lerman, A., & Lerman, L. O.
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer International Publishing
- Published
- 2016
- Volume
- 240
- Pages
- 229-250
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W2436471876
- Cited by
- 99
- References
- 11
- FWCI
- 8.26
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Emerging Role of Mitochondrial Targeting in Kidney Disease. https://app.cochat.ai/papers/10.1007/164_2016_6
- The paper
- Eirin, A., Lerman, A., & Lerman, L. O. (2016). The Emerging Role of Mitochondrial Targeting in Kidney Disease. Handbook of Experimental Pharmacology. https://doi.org/10.1007/164_2016_6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.